Canada Israel technology innovation cooperation: Call for proposals for joint projects

Expressions of Interest (EOIs) are being accepted now. Full proposals and funding applications will be accepted immediately following an approved EOI.

Introduction

This call for Canada‑Israel Technology Innovation partnerships evolved from the joint prime ministerial initiative for holding the Canada‑Israel Technology Innovation Summits 2010 and 2011 aiming to strengthen the technology innovation partnership through sustainable cooperation mechanisms to generate mutual economic advantage.

Responsibility for coordinating this joint activity was placed in Israel on the Office of the Chief Scientist (OCS) in the Israel Ministry of Industry Trade and Labor, through MATIMOP – the Israeli Industry Center for R&D, and in Canada on the National Research Council (NRC).

The call for proposals between MATIMOP and NRC is now launched in this framework, aiming to facilitate and support collaborative projects in designated areas of cooperation. Joint projects in this framework will be funded through existing OCS and NRC mechanisms and may be leveraged by other investment.

Submission of proposals and approvals of collaborative projects will be in line with the EUREKA procedures, noting Israel's status as a EUREKA member and Canada's status as an associate member.

Technological Fields

The main objective of this Call for Proposals is to stimulate generation of joint project proposals in the following technological and industrial fields:

  1. Renewable and Alternative Energy
  2. Water Recovery and Treatment Solutions
  3. Brain and Brain-related Research
  4. Other technologies as proposed

Modes of Collaboration

This Call for Proposals offers two collaboration tracks.

Mode I: Individual Industrial R&D Projects involving at least one Israeli R&D performing company and one Canadian R&D performing SME. Participation of research institutions/universities is welcome as subcontractors according to each country's funding regulations. Submission of EOIs under this mode is open immediately and EOIs are being accepted and reviewed as submitted.

Mode II: Developing Pre-Commercial Technologies through joint consortia. Submission of EOIs in this mode is open. This collaboration mode may also include project generation activities (e.g. joint seminars and workshops) to be organized by the Program coordinators in NRC and MATIMOP. The events schedule will be announced separately.

In both cooperation modes, third parties from additional countries, particularly from EUREKA member countries, may also participate in the projects, subject to the applicable EUREKA regulations and the respective national rules and procedures. These third parties will not be eligible for funding from the Israeli and/or Canadian side.

Call Structure

The submission and the approval process consist of two phases:

Phase 1: Joint Submission of an EOI. In the first phase, the completed EOI Application FormFootnote 1 (in English Footnote 2) should be submitted to MATIMOP in Israel and to NRC in Canada simultaneously. Recommendations will be conveyed to applicants.

The forms must be legally signed by all participating entities. The signatures must be scanned and sent electronically together with the EOI Application Form.

Prior consultation with the respective organizations (MATIMOP in Israel and NRC in Canada) is strongly advised. MATIMOP/OCS and NRC will screen the EOIs and decide which will be invited to submit a Full ProposalFootnote 3.

Note: A positive recommendation in the EOI phase does not imply approval of the Full Proposal.

Phase 2: Submission of Full Proposal / Parallel Applications for Funding respectively to MATIMOP/OCS and NRC.

Applicants invited to submit a Full Proposal must complete the EUREKA Project FormFootnote 4 and complete any national funding applications according to national proceduresFootnote 5 applicable for Mode I or Mode II applications.

For the Full Proposal, the applicants must attach a draft cooperation agreementFootnote 6. Signing the final cooperation agreement will be a prerequisite for receiving funding.

Each country will fund its eligible participants under the EUREKA framework. The EUREKA status (E! Label) may only be granted when the funding of all project partners has been secured, either through public funding schemes or self-funding.

Mode I Mode II
Description Individual Industrial R&D Projects involving at least one Israeli R&D performing company and one Canadian R&D performing SME.

Participation of research institutions/universities is welcome as subcontractors according to each country's funding regulations.
Developing Pre-Commercial Technologies through joint consortia.

This collaboration mode may also include project generation activities (e.g. joint seminars and workshops) to be organized by the Program coordinators in NRC and MATIMOP. The events schedule will be announced separately.
Technological Fields
  • Renewable and Alternative Energy
  • Water Recovery and Treatment Solutions
  • Brain and Brain-related Research
  • Other technologies as proposed
  • Renewable and Alternative Energy
  • Water Recovery and Treatment Solutions
  • Brain and Brain-related Research
  • Other technologies as proposed
Funding EligibilityFootnote 7 In Canada:
NRC‑IRAP eligible SMEs. Universities and Research Centers can participate as sub-contractors.
In Canada:
NRC‑IRAP eligible SMEs.
Eligible NRC research programs. Other firms, research institutes and universities are welcome in the consortia with self-funding and/or other identified public funding.
In Israel:
R&D performing companies registered and operating in Israel. Universities and Research Centers can participate as sub-contractors, in line with OCS applicable rules and procedures.
In Israel:
Eligible consortia for including a Canadian participant are MAGNET consortia comprised of industrial firms and research institutions that have been approved by the MAGNET committee, in line with OCS-MAGNET rules and procedures.
Deadlines Phase 1: EOI
EOIs are being accepted now.

Recommendations will be conveyed to applicants within four weeks following EOI submission.

Phase 2 (by invitation): Full Proposal
Open upon invitation and Full Proposals will be accepted upon invitation.
Phase 1: EOI
EOIs are being accepted now.

Recommendations will be conveyed to applicants within four weeks following EOI submission.

Phase 2 (by invitation): Full Proposal
Open upon invitation and Full Proposals will be accepted upon invitation.
Common Requirements and Evaluation Criteria
  • Applicants are expected to develop technology-based products, services or methods which have strong market potential globally.
  • The project should have an obvious advantage and added value resulting from the cooperation between the participants from the two countries (e.g. increased knowledge base, commercial leads, access to R&D infrastructure, new fields of application, etc.).
  • The project should demonstrate the contribution of the participants from both countries.
  • The partners in Israel and in Canada must agree in advance on the IP rights and on a commercialization strategy for the product or process.
  • The partners in Israel and in Canada must be capable of implementing the project and be financially viable in order to fund their respective share.
  • The joint project must demonstrate adequate balance among the participants and significance to both sides.
  • Projects should be intended to provide a competitive position for Israel's and Canada's industry respectively, with regard to state-of-the-art technologies of global interest.
  • The new technologies are to be developed in a cooperative venture between the industry and research institutions having an appropriate expertise in the field.
  • The joint projects must be of generic, pre-competitive nature. This definition refers to a broad spectrum of common technologies, components, materials, design and manufacturing methods and processes, standards and protocols, which have wide ranging applications in numerous industries.
  • The partners in Israel and in Canada must agree in advance on the IP rights and on a commercialization strategy for future products resulting from the project.
Scope of Funding In Canada:
Financial support for participating Canadian SMEs may be provided by NRC- IRAP for eligible research and development activities, by supporting a portion of salary and contractor costs associated with the project. Total support for the firm in the form of a non repayable contribution will not exceed 75% of its total costs in the project.
In Canada:
Financial support for participating Canadian SMEs may be provided by NRC- IRAP for eligible research and development activities, by supporting a portion of salary and contractor costs associated with the project. Total support for the firm in the form of a non repayable contribution will not exceed 75% of its total costs in the project.

Investment for NRC research programs will be provided by NRC.
In Israel:
Conditional grants from OCS R&D fund not exceeding 50% of the eligible and approved costs of the R&D, in accordance with the applicable laws and regulations. Additional top-ups may apply to companies operating in developing zones. Further details regarding grants and payment of royalties are available at the OCS website.
In Israel:
As in Mode I. Additional OCS funding instruments may apply (e.g. Magneton, Nofar etc.) and will be discussed on a per case basis with the applicants.
Self Funding In line with EUREKA practices, a project partner may choose to self fund its share in the project without applying to its national authority for funding. In such a case, applicants on the Israeli side must submit a National Application Form, EUREKA form and draft cooperation agreement. Applicants on the Canadian side must still submit a EUREKA Project Form and a draft cooperation agreement. All applicants must follow additional instructions that will be provided by the Program Coordinators in Canada or Israel.

Please contact NRC or MATIMOP in the early stage to discuss your plans to participate in this call and to hear about the procedure and any additional requirements to participate.

Contacts

Canada

Bill Dobson (for Canadian SMEs)
National Project Coordinator (SMEs)
EUREKA National Office - Canada
Telephone: +1-416-954-8330
EmailWilliam.Dobson@nrc-cnrc.gc.ca

Mark Burbidge (for non-SME applicants)
Deputy National Project Coordinator
EUREKA National Office - Canada
Membership in EUREKA
Telephone: +1-613-990-1848
EmailMark.Burbidge@nrc-cnrc.gc.ca

Israel

Liron Eldar
Program Manager – North American Desk
MATIMOP – Israeli Industry Center for R&D
Telephone: 972-3-5118155
EmailLiron@matimop.org.il

Footnotes

Footnote 1

To obtain an EOI template, and prior to submission, please connect with the appropriate contact listed at the end of this document.

Return to footnote 1 referrer

Footnote 2

Note: The working language of the EUREKA Secretariat is English; therefore all EUREKA forms must be completed in English. National forms will be accepted in the official language of choice.

Return to footnote 2 referrer

Footnote 3

Form to be provided to successful EOI proposals only.

Return to footnote 3 referrer

Footnote 4

Eureka network application form.

Return to footnote 4 referrer

Footnote 5

On the Israeli side: For Mode I. For Mode II. On the Canadian side: For Mode I (NRC‑IRAP eligible SMEs). For Mode II, please contact NRC International Relations for details.

Return to footnote 5 referrer

Footnote 6

Draft model agreement will be supplied upon request or at the Full Proposal phase.

Return to footnote 6 referrer

Footnote 7

Please contact NRC or MATIMOP in the early stage to discuss your plans to participate in this call and to hear about the procedure and any additional requirements to participate.

Return to footnote 7 referrer